CORT
Corcept Therapeutics Incorporated
88.48
2 x 82.74
2 x 96.82
bid
ask
+
1.53
1.76%
2 @ 04:00 PM
88.78 +0.30 (0.34%)
| Ytd | 154.25% | |
| 1y | 27.66% |
86.04
day range
91.00
28.66
52 week range
91.00
| Open | 87.07 | Prev Close | 86.95 | Low | 86.04 | High | 91.00 | Mkt Cap | 9.50B |
| Vol | 1.04M | Avg Vol | 1.10M | EPS | 0.35 | P/E | 252.80 | Forward P/E | 34.85 |
| Beta | 0.50 | Short Ratio | 8.55 | Inst. Own | 75.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 65.44 | 200-d Avg | 60.49 | 1yr Est | 88.00 |
| Income Statement | |||
| Total Revenue | 164.90M | ||
| Revenues (USD) | 164.90M | ||
| Cost of Revenue | 2.88M | ||
| Gross Profit | 162.02M | ||
| Operating Expenses | 211.62M | ||
| Research and Development Expense | 66.27M | ||
| Selling, General and Administrative Expense | 145.36M | ||
| Operating Income | -49.60M | ||
| Interest Expense | -4.89M | ||
| Income Tax Expense | -12.95M | ||
| Net Income | -31.20M | ||
| Net Income Common Stock | -31.20M | ||
| Net Income Common Stock (USD) | -31.20M | ||
| Consolidated Income | -31.76M | ||
| Net Income to Non-Controlling Interests | -559.00K | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -49.04M | ||
| Earning Before Interest & Taxes (USD) | -49.04M | ||
| Weighted Average Shares | 104.44M | ||
| Weighted Average Shares Diluted | 104.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 108.74M | ||
| Cash and Equivalents (USD) | 108.74M | ||
| Investments | 406.71M | ||
| Investments Current | 229.45M | ||
| Investments Non-Current | 177.26M | ||
| Trade and Non-Trade Receivables | 39.07M | ||
| Current Assets | 426.03M | ||
| Property, Plant & Equipment Net | 10.37M | ||
| Total Assets | 814.88M | ||
| Debt Current | 1.63M | ||
| Total Debt | 9.64M | ||
| Current Liabilities | 149.19M | ||
| Debt Non-Current | 8.01M | ||
| Total Liabilities | 176.89M | ||
| Accumulated Retained Earnings (Deficit) | 611.63M | ||
| Accumulated Other Comprehensive Income | 918.00K | ||
| Shareholders Equity | 637.99M | ||
| Shareholders Equity (USD) | 637.99M | ||
| Assets Non-Current | 388.85M | ||
| Total Debt (USD) | 9.64M | ||
| Inventory | 27.40M | ||
| Liabilities Non-Current | 27.71M | ||
| Trade and Non-Trade Payables | 33.31M | ||
| Tax Assets | 181.56M | ||
| Tax Liabilities | 15.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 598.00K | ||
| Net Cash Flow from Financing | 760.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.76M | ||
| Capital Expenditure | -201.00K | ||
| Issuance (Purchase) of Equity Shares | 760.00K | ||
| Net Cash Flow from Investing | 4.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.74M | ||
| Net Cash Flow from Operations | -16.77M | ||
| Effect of Exchange Rate Changes on Cash | -287.00K | ||
| Share Based Compensation | 23.04M | ||